Immunomodulators for allergic respiratory disorders
- 1 February 2008
- journal article
- review article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 121 (2), 288-296
- https://doi.org/10.1016/j.jaci.2007.11.040
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Antiinfective Applications of Toll-like Receptor 9 AgonistsProceedings of the American Thoracic Society, 2007
- Eat Dirt: CpG DNA and Immunomodulation of AsthmaProceedings of the American Thoracic Society, 2007
- Development of TLR9 agonists for cancer therapyJCI Insight, 2007
- Efficacy of anti-IgE therapy in patients with atopic dermatitisJournal of the American Academy of Dermatology, 2006
- Treatment of recalcitrant atopic dermatitis with omalizumabJournal of the American Academy of Dermatology, 2006
- Failure of omalizumab for treatment of severe adult atopic dermatitisJournal of the American Academy of Dermatology, 2005
- Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆Journal of Allergy and Clinical Immunology, 2004
- Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2003
- Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2002
- OmalizumabDrugs, 2001